CEO Paul Hudson talks about latest Sanofi headlines at the Financial Times' Global Pharma and Biotech Summit on Nov. 8. (Credit: Reynald Castañeda for Endpoints News)
November 9, 2023 03:39 AM ESTUpdated 06:01 AM
People
Pharma

Sanofi CEO re­it­er­ates R&D bet is best long-term ap­proach, ad­dress­es probe on mar­ket ma­nip­u­la­tion al­le­ga­tions

Reynald Castañeda

Deputy Editor

Al­though Sanofi CEO Paul Hud­son was at the Fi­nan­cial Times’ Glob­al Phar­ma and Biotech Sum­mit to talk about AI, there was no avoid­ing the ques­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times